Zealand Pharma taps Generate’s AI in obesity deal worth up to $1.2 billion

Your call?🐂 Bullish🐻 Bearish

$1.2B

AI obesity deal

Zealand's AI-driven obesity drug collaboration could redefine treatment strategies, emphasizing multispecific proteins for complex conditions.